Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-052644)

Filing Details

Accession Number:: 0001209191-14-052644
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-15 14:41:04
Reporting Period:: 2014-08-13

Filing Date:: 2014-08-15
Accepted Time:: 2014-08-15 14:41:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949699	Pharmacyclics Inc	PCYC	Pharmaceutical Preparations (2834)	943148201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559231	Maria Fardis	C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085	Chief Of Oncology Ops & Allian	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-13	4,000	$6.84	7,192	No	4	M	Direct
Common Stock	Disposition	2014-08-13	4,000	$121.01	3,192	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-13	4,000	$0.00	4,000	$6.84

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
51,393	2011-05-20	2021-05-20	No	4	M	Direct

Footnotes

The shares subject to the option will vest as follows: 16,250 of the total shares subject to the option (65,000 shares) vested on April 25, 2012 and 1/36th of the remaining shares will vest monthly thereafter.